UBS lowered the firm’s price target on FMC (FMC) to $15 from $17 and keeps a Neutral rating on the shares. UBS is not modeling a major change in the macro in 2026, the analyst tells investors in a research note.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMC: